Merck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive agreement to acquire Mirus Bio in a $600m (€500m) deal. The move aims to enhance Merck’s ...
The NIIMBL supported training network is in its pilot stage and includes UMass Lowell, UMass Dartmouth, Mass Biologics, and MIT with industry input from Merck & Co., Pfizer, and Millipore Sigma. The ...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, and Opentrons Labworks, Inc., a ...
BURLINGTON, Mass.--(BUSINESS WIRE)--MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced that the Life Science business of Merck KGaA, Darmstadt ...